China Supply Piperacillin Sodium and Tazobactam Sodium Injection, USP Powder, Lyophilized, for Solution

• Transport Package: 6kgs/Drum
• Specification: 99%
• Trademark: NCPC
• Origin: China
• Model NO.: ITB-PST091
• HS Code: 2941109900
• Production Capacity: 1billion/Year

Product Description

Piperacillin Sodium and Tazobactam Sodium Injection,USP powder, lyophilized, for Solution

Dosage Forms & Strengths

injection, lyophilized powder for reconstitution

• (2g/250mg)/vial: 2.25g
• (3g/375mg)/vial: 3.375g
• (4g/500mg)/vial: 4.5g
• (36g/4.5g)/vial: 40.5g

premix bag

• 2.25g/50mL
• 3.375g/50mL
• 4.5g/100mL

Intra-abdominal Infections

Indicated for treatment of appendicitis (complicated by rupture or abscess) and peritonitis caused by beta-lactamase producing isolates of Escherichia coli or the following members of the Bacteroides fragilis group: B fragilis, B ovatus, B thetaiotaomicron, or B vulgatus

3.375 g IV q6hr (totaling 13.5 g [12 g piperacillin/1.5 g tazobactam]) for 7-10 days

Nosocomial Pneumonia

Indicated for treatment of nosocomial pneumonia (moderate to severe) caused by beta-lactamase producing isolates of Staphylococcus aureus and by piperacillin/tazobactam-susceptible Acinetobacter baumannii, Haemophilus influenzae, Klebsiella pneumoniae, and Pseudomonas aeruginosa

Nosocomial pneumonia caused by P aeruginosa should be treated in combination with an aminoglycoside

4.5 g IV q6hr (totaling 18 g [16 g piperacillin/2 g tazobactam]) for 7-14 days; continue aminoglycoside in P. aeruginosa patients

Skin and Skin Structure infections

Indicated for treatment of uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses and ischemic/diabetic foot infections caused by beta-lactamase producing isolates of Staphylococcus aureus

3.375 g IV q6hr (totaling 13.5 g [12 g piperacillin/1.5 g tazobactam]) for 7-10 days

Female Pelvic Infections

Indicated in treatment of postpartum endometritis or pelvic inflammatory disease caused by beta-lactamase producing isolates of E coli

3.375 g IV q6hr (totaling 13.5 g [12 g piperacillin/1.5 g tazobactam]) for 7-10 days

Community-acquired Pneumonia

Indicated for the treatment of community-acquired pneumonia (moderate severity only) caused by beta-lactamase producing isolates of H influenzae

3.375 g IV q6hr (totaling 13.5 g [12 g piperacillin/1.5 g tazobactam]) for 7-10 days

Dosage Modifications

Renal impairment

• All indications except nosocomial pneumonia

  • CrCl >40 mL/min: 3.375 g IV q6hr
  • CrCl 20-40 mL/min (without hemodialysis): 2.25 IV q6hr
  • CrCl <20 mL/min (without hemodialysis): 2.25 g IV q8hr
  • Hemodialysis: 2.25 g IV q12hr; administer an additional dose of 0.75 g (0.67 g piperacillin/0.08 g tazobactam) following each dialysis period on hemodialysis days
  • CAPD: 2.25 g IV q12hr

• Nosocomial pneumonia

  • CrCl >40 mL/min: 4.5 g IV q6hr
  • CrCl 20-40 mL/min (without hemodialysis): 3.375 IV q6hr
  • CrCl <20 mL/min (without hemodialysis): 2.25 g IV q6hr
  • Hemodialysis: 2.25 g IV q8hr; administer an additional dose of 0.75 g (0.67 g piperacillin/0.08 g tazobactam) following each dialysis period on hemodialysis days
  • CAPD: 2.25 g IV q8hr

Hepatic impairment

• Dosage adjustment not warranted in patients with hepatic cirrhosis

Cystic fibrosis patients

• As with other semisynthetic penicillins, piperacillin therapy has been associated with an increased incidence of fever and rash in cystic fibrosis patients

Dosing Considerations

Administering drug in absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases risk of development of drug-resistant bacteria

When culture and susceptibility information are available, consider selecting or modifying antibacterial therapy

In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy

 

Our Advantages

1. Quick delivery
2. Online payment
3. Quality assurance
4. Welcome big order
5. After-sales service 24 hours
6. Competitive advantage products
7. Our value information is "Quality is our culture"
8. Work with us to provide you with secure funds, your business is securely protected, our advantages

After Sales Service

a)  Free amples can be provided.
b) Guide customers through professional technology and teach them how to use our products after sale
c) Determine the lowest price of high-quality products
1. Skilled experience: Our company is a leading manufacturer of professional production in China pharmaceutical field for many years.
2. The highest quality: to ensure high quality, once any problems are found, the package will be re-shipped for you.
3. Safe transportation: by air express (FedEx, UPS, DHL, EMS). It is recommended that you choose the most professional freight forwarder.
4. Fast delivery: We have stock, so once payment is received, we can deliver quickly.
5. Quality service: We will provide you with enthusiastic after-sales service. If you have any questions, we will reply to youwithin 24 hours.
6. Competitive price: discounts will be obtained when making large orders.
 

FAQ

1.who are we?
We are based in Fujian, China, start from 2000,sell to North America(40.00%),Southeast Asia(25.00%),Western Europe(25.00%),Africa(10.00%).There are total about 50 people in our office.

2. how can we guarantee quality?
Always a pre-production sample before mass production;
Always final Inspection before shipment;

3.what can you buy from us?
Pharmaceutical production lines,Intermediates,APIs,Finished Drug Preparations & Vaccines.

4. why should you buy from us not from other suppliers?
We have our own manufacture factories and one professional sales team working for the clients all over the world.

5. what services can we provide?
Accepted Delivery Terms: FOB,CIF,EXW,DDP,Express Delivery;
Accepted Payment Currency:USD,EUR,CAD,AUD,GBP,CNY;
Accepted Payment Type: T/T,L/C,PayPal,Western Union;
Language Spoken:English,Chinese,Japanese

Company Profile

 

ITB Biopharm Co., Ltd is a comprehensive enterprise which integrates R & D, production and construction of pharmaceutical production equipments, development and transfer of biotechnology, and cooperative production and sales of drugs and vaccines. The self-developed pharmaceutical production equipment branded ITB has been put into operation in many well-known pharmaceutical enterprises such as NCPC&CSPC and also cooperates with many well-known pharmaceutical enterprises in production and sales, including pharmaceutical intermediates, APIs and finished drug preparations.

ITB Biopharm Co., Ltd business radiates to all levels, including direct supply cooperation with government departments and industry representatives, as well as establishing supply cooperation relationship with retail industry. We supply high quality, safe and effective medicines and medical equipment to governments, hospitals, clinics and licensed pharmacies in different countries with timely and effective services at reasonable prices.

At present ITB Biopharm Co., Ltd has NCPC offical authorization to sell its Intermediates,APIs and Finished Prepartions which is produced by NCPC North Best and its own sister manufactures,then ITB Biopharm Co., Ltd is the only manufacture in China which can supply the complete service from pharmaceutical produciton lines,intermediates and APIs to finished drug preparations and vaccines.Then we are seeking the professional pharmaceutical enterprices to work together for further cooperations.
 

Factory View

Our Business

Our Products